RGEN

Conclusions

• 🟢Price vs. SMA 50 — Price is above the 50-day average
• 🟢Price vs. SMA 200 — Price is above the 200-day average
• 🟢MACD — MACD histogram is positive — rising momentum
• 🟢RSI — RSI 66.1 — healthy positive momentum
• 🔴Stochastic — %K 98.8 — overbought
• 🟢ADX (trend strength) — ADX 27.6 — strong trend
• 🔴Volume trend — Volume is falling despite the price advance — possible weakening
• 🟢Relative strength vs. S&P 500 — +21.5% over the last 3 months relative to the index
• 🟢Bollinger Bands — Price is in the upper third of the Bollinger Bands (111%B) — strong momentum (risk of a pullback)
• 🟢ROC (rate of change) — ROC 12 days: 9.0%
• 🟢Parabolic SAR — Price is above the SAR point — uptrend
• 🟢CMF (money flow) — CMF 20 days: 0.15

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = support minusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Profit Targets by Risk/Reward Ratio (R)

Conclusions

• 🟢Gross margin — Gross margin: 52.3% — strong
• 🔴Operating margin — Operating margin: 7.5% — weak
• 🟡Net margin — Net margin: 6.6% — reasonable
• 🔴Return on equity (ROE) — Return on equity (ROE): 2.3% — weak
• 🔴Return on assets (ROA) — Return on assets (ROA): 1.7% — weak
• 🟢Current ratio (liquidity) — Current ratio: 8.37
• 🟢Debt-to-equity — Debt/equity: 0.26
• 🟡Interest coverage — Interest coverage: 2.4x

Conclusions

• 🟢Revenue growth (last year) — Revenue growth (last year): 16.4%
• 🟢Earnings per share (EPS) growth — Earnings per share (EPS) growth: 287.0%
• 🔴Free cash flow growth — Free cash flow growth: -37.3%
• 🟢Net income growth — Net income growth: 291.6%

Conclusions

• 🟢DCF Fair Value — Estimated fair value: $24,286.22 vs. price $159.44 (+15132.2%)
• 🟢Tangible Net Asset Value (NAV) — NAV per share: $10,706.56
• 🔴P/E — P/E: 184.4